These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31103487)

  • 1. Nocebo response in Parkinson's disease: A systematic review and meta-analysis.
    Leal Rato M; Duarte GS; Ferreira AN; Alves M; Mainoli B; Teodoro T; Mestre TA; Costa J; Ferreira JJ
    Parkinsonism Relat Disord; 2019 Aug; 65():13-19. PubMed ID: 31103487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of placebo-arm dropouts in osteoporosis randomized-controlled trials and implications for nocebo-associated discontinuation of anti-osteoporotic drugs in clinical practice.
    Kravvariti E; Kasdagli MI; Diomatari KM; Mouratidou P; Daskalakis K; Mitsikostas DD; Sfikakis PP; Yavropoulou MP
    Osteoporos Int; 2023 Mar; 34(3):585-598. PubMed ID: 36596944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo and nocebo responses in randomized controlled trials of Janus kinase inhibitor monotherapy for rheumatoid arthritis : A meta-analysis.
    Sung YK; Lee YH
    Z Rheumatol; 2022 Jun; 81(5):430-437. PubMed ID: 33687525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid overview of systematic reviews of nocebo effects reported by patients taking placebos in clinical trials.
    Howick J; Webster R; Kirby N; Hood K
    Trials; 2018 Dec; 19(1):674. PubMed ID: 30526685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo and Nocebo Responses in Pharmacological Trials of Tic Disorders: A Meta-Analysis.
    Wang S; Xiong Z; Cui Y; Fan F; Zhang S; Jia R; Hu Y; Li L; Zhang X; Han F
    Mov Disord; 2024 Mar; 39(3):585-595. PubMed ID: 38247265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nocebo in Alzheimer's disease; meta-analysis of placebo-controlled clinical trials.
    Zis P; Mitsikostas DD
    J Neurol Sci; 2015 Aug; 355(1-2):94-100. PubMed ID: 26073486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nocebo responses in randomized controlled trials of COVID-19 vaccines.
    Lee YH; Song GG
    Int J Clin Pharmacol Ther; 2022 Jan; 60(1):5-12. PubMed ID: 34622766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo and nocebo responses in restless legs syndrome: A systematic review and meta-analysis.
    Silva MA; Duarte GS; Camara R; Rodrigues FB; Fernandes RM; Abreu D; Mestre T; Costa J; Trenkwalder C; Ferreira JJ
    Neurology; 2017 Jun; 88(23):2216-2224. PubMed ID: 28490647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nocebo-associated treatment discontinuation with subcutaneous anti-osteoporotic drugs. A systematic review and meta-analysis of placebo-arm dropouts in randomized-controlled trials.
    Yavropoulou MP; Kasdagli MI; Makras P; Diomatari KM; Anastasilakis AD; Mitsikostas DD; Kassi E; Sfikakis PP; Kravvariti E
    Maturitas; 2024 Jan; 179():107874. PubMed ID: 37976923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nocebo effects and influencing factors in the randomized clinical trials of chronic constipation: A systematic review and meta-analysis.
    Yang J; Guo J; Yang X; Chen J; Bai T; Liu S
    Neurogastroenterol Motil; 2024 Feb; 36(2):e14708. PubMed ID: 37936549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo and nocebo responses in randomised controlled trials of drugs applying for approval for fibromyalgia syndrome treatment: systematic review and meta-analysis.
    Häuser W; Sarzi-Puttini P; Tölle TR; Wolfe F
    Clin Exp Rheumatol; 2012; 30(6 Suppl 74):78-87. PubMed ID: 23137770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nocebo response intensity and influencing factors in the randomized clinical trials of functional dyspepsia: A systematic review and meta-analysis.
    Li RJ; Zhang QQ; Feng YQ; Pei QQ; He XX; Chen FP; Wang DK; Liu XH; Liu JS; Hou XH; Bai T
    J Dig Dis; 2023; 24(8-9):440-451. PubMed ID: 37577771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of the Placebo and Nocebo effects associated with Placebo treatment in randomized trials of lipid-lowering therapies.
    Chin YH; Lim O; Lin C; Chan YY; Kong G; Ng CH; Chong B; Syn N; Chan KE; Muthiah MD; Siddiqui MS; Wang JW; Figtree G; Chan MY; Chew NWS
    Eur Heart J Qual Care Clin Outcomes; 2023 Aug; 9(5):511-519. PubMed ID: 36107462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo and nocebo reactions in randomized trials of pharmacological treatments for persistent depressive disorder. A meta-regression analysis.
    Meister R; Jansen A; Härter M; Nestoriuc Y; Kriston L
    J Affect Disord; 2017 Jun; 215():288-298. PubMed ID: 28363152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nocebo in cerebellar ataxia: A systematic review and meta-analysis of placebo-controlled clinical trials.
    Alam JM; Hadjivassiliou M; Zis P
    J Neurol Sci; 2019 Jun; 401():112-117. PubMed ID: 31075682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nocebo Response in the Pharmacological Management of Overactive Bladder: A Systematic Review and Meta-analysis.
    Mostafaei H; Mori K; Quhal F; Miura N; Motlagh RS; Pradere B; Laukhtina E; Lysenko I; Ghaffari S; Hajebrahimi S; Shariat SF
    Eur Urol Focus; 2021 Sep; 7(5):1143-1156. PubMed ID: 33153953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What influences placebo and nocebo responses in Parkinson's disease?
    Witek N; Stebbins GT; Goetz CG
    Mov Disord; 2018 Aug; 33(8):1204-1212. PubMed ID: 30132980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nocebo effects and psychotropic drug action.
    Amanzio M
    Expert Rev Clin Pharmacol; 2015 Mar; 8(2):159-61. PubMed ID: 25494811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nocebo response intensity and influencing factors in the randomized clinical trials of irritable bowel syndrome: A systematic review and meta-analysis.
    Li R; Chen F; He X; Feng Y; Pei Q; Wang D; Liu X; Liu J; Hou X; Bai T
    Front Med (Lausanne); 2022; 9():1018713. PubMed ID: 36606047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events attributable to nocebo in randomized controlled drug trials in fibromyalgia syndrome and painful diabetic peripheral neuropathy: systematic review.
    Häuser W; Bartram C; Bartram-Wunn E; Tölle T
    Clin J Pain; 2012 Jun; 28(5):437-51. PubMed ID: 22336767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.